Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Molecular Modeling"
DOI: 10.1007/s00894-024-05935-y
Abstract: SHP2 is a non-receptor protein tyrosine phosphatase to remove tyrosine phosphorylation. Functionally, SHP2 is an essential bridge to connect numerous oncogenic cell-signaling cascades including RAS-ERK, PI3K-AKT, JAK-STAT, and PD-1/PD-L1 pathways. This study aims to discover…
read more here.
Keywords:
simulation;
shp2;
virtual screening;
allosteric inhibitor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Computer-Aided Molecular Design"
DOI: 10.1007/s10822-020-00332-y
Abstract: The exchange proteins activated by cAMP (EPAC) are implicated in a large variety of physiological processes and they are considered as promising targets for a wide range of therapeutic applications. Several recent reports provided evidence…
read more here.
Keywords:
allosteric inhibitor;
modeling epac1;
molecular dynamics;
interactions allosteric ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cell chemical biology"
DOI: 10.1016/j.chembiol.2019.02.006
Abstract: SUMOylation is a post-translational modification with important roles in normal physiology and whose dysregulation is associated with human diseases. In this issue of Cell Chemical Biology, Li et al. (2019) describe a covalent, allosteric inhibitor of…
read more here.
Keywords:
covalent allosteric;
allosteric inhibitor;
biology;
inhibitor sumo ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cell chemical biology"
DOI: 10.1016/j.chembiol.2021.11.004
Abstract: DnaK is the bacterial homolog of Hsp70, an ATP-dependent chaperone that helps cofactor proteins to catalyze nascent protein folding and salvage misfolded proteins. In the pathogen Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), DnaK…
read more here.
Keywords:
bacterial hsp70;
allosteric inhibitor;
inhibitor bacterial;
chaperone ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "International journal of biological macromolecules"
DOI: 10.1016/j.ijbiomac.2016.12.025
Abstract: Akt, a serine/threonine protein kinase, is often hyper activated in breast and prostate cancers, but with poor prognosis. Allosteric inhibitors regulate aberrant kinase activity by stabilizing the protein in inactive conformation. Several natural compounds have…
read more here.
Keywords:
allosteric inhibitor;
inactive conformation;
natural allosteric;
inhibitor akt1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of agricultural and food chemistry"
DOI: 10.1021/acs.jafc.4c03023
Abstract: Currently, allosteric inhibitors have emerged as an effective strategy in the development of preservatives against the drug-resistant Botrytis cinerea (B. cinerea). However, their passively driven development efficiency has proven challenging to meet the practical demands.…
read more here.
Keywords:
relational inference;
allosteric inhibitor;
neural relational;
chitinase ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-018-0178-6
Abstract: Inhibitors of phosphodiesterase-4 (PDE4) have beneficial effects on memory in preclinical and clinical studies. Development of these drugs has stalled due to dose-limiting side effects of nausea and emesis. While use of subtype-selective inhibitors (i.e.,…
read more here.
Keywords:
effects bpn14770;
allosteric inhibitor;
bpn14770 allosteric;
wild type ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Acta Pharmacologica Sinica"
DOI: 10.1038/s41401-020-0399-1
Abstract: Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as erlotinib, remains a major challenge in the targeted therapy of non-small cell lung cancer (NSCLC). HKB99 is a novel allosteric inhibitor of…
read more here.
Keywords:
allosteric inhibitor;
inhibitor;
erlotinib resistant;
invasive pseudopodia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Nature Communications"
DOI: 10.1038/s41467-018-07015-1
Abstract: E1 enzymes activate ubiquitin (Ub) and ubiquitin-like modifiers (Ubls) in the first step of Ub/Ubl conjugation cascades and represent potential targets for therapeutic intervention in cancer and other life-threatening diseases. Here, we report the crystal…
read more here.
Keywords:
covalent allosteric;
allosteric inhibitor;
mechanism;
sumo ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-60784-y
Abstract: Abnormal regulation of β-catenin initiates an oncogenic program that serves as a main driver of many cancers. Albeit challenging, β-catenin is an attractive drug target due to its role in maintenance of cancer stem cells…
read more here.
Keywords:
allosteric inhibitor;
inhibitor catenin;
catenin;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Chemical Science"
DOI: 10.1039/d5sc04324g
Abstract: The NRF2 transcription factor is constitutively active in various cancers, functioning as an oncogenic driver for tumor progression and chemo/radiotherapy resistance. Despite the well-documented role of NRF2 overactivation in cancer, no targeted therapy is currently…
read more here.
Keywords:
phenotypic screening;
cancer;
nrf2 driven;
allosteric inhibitor ... See more keywords